This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Diamond-Blackfan Anemia

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Diamond-Blackfan Anemia Means

Diamond-Blackfan Anemia (DBA) is a very rare inherited blood disorder where the bone marrow does not produce enough red blood cells. Red blood cells carry oxygen from the lungs to the rest of the body, so having too few can cause symptoms like tiredness, weakness, and pale skin. DBA usually appears during the first year of life, often in babies under one year old. It is caused by changes in certain genes that affect ribosomes, tiny parts inside cells that help make proteins. These proteins are essential for many body functions, including making new blood cells. Because of these gene changes, the bone marrow cannot produce enough red blood cells.

Besides anemia, some children with DBA may have physical differences such as deformed thumbs or other skeletal abnormalities. These physical signs can help doctors recognize the condition early. DBA is also known by several other names, including Blackfan–Diamond anemia, congenital hypoplastic anemia, congenital pure red cell aplasia, erythrogenesis imperfecta, and inherited erythroblastopenia. These terms all describe the same problem of low red blood cell production from birth.

Why Diamond-Blackfan Anemia Matters in Cancer Care

People with Diamond-Blackfan Anemia have a higher risk of developing certain cancers, especially leukemia, which is a cancer of the blood cells, and sarcomas, which are cancers of connective tissues like bone. Osteosarcoma, a type of bone cancer, is particularly noted in this group. This increased cancer risk means that ongoing monitoring and careful medical follow-up are important parts of care for patients with DBA. However, having DBA does not mean a person will definitely develop cancer, only that their risk is higher than average.

What Patients and Caregivers Might Experience

If your child is diagnosed with DBA, you may notice symptoms related to anemia such as fatigue or pale skin. You might also see physical differences like thumb deformities. The diagnosis can come with many different names, which can be confusing. It’s helpful to ask your healthcare team to explain the diagnosis clearly and what it means for treatment and monitoring. Doctors may recommend regular blood tests to check red blood cell levels and watch for signs of cancer or other complications. Treatment might include blood transfusions or medications to manage anemia. Genetic counseling may also be offered to understand the inherited nature of the condition and its implications for family members.

How Doctors Use This Term

The term Diamond-Blackfan Anemia or its other names may appear in medical reports, treatment plans, genetic counseling notes, or discussions about cancer risk. Doctors use this diagnosis to guide treatment decisions, such as managing anemia symptoms and planning regular monitoring for cancer or other health issues. Understanding the different names for this condition can help avoid confusion when reading medical information or reports.

Common Sources of Confusion and Next Steps

Because Diamond-Blackfan Anemia is known by several names, patients and caregivers might see different terms used in medical records or discussions. Comparing the wording and asking your healthcare team to clarify can help avoid misunderstandings. It is important to remember that having DBA means a higher risk of certain cancers but does not guarantee cancer will develop. Careful management and follow-up are key to maintaining health.

This information is educational and cannot decide what is safe or appropriate for any individual. If you see this term in a medical report or hear it from your care team, the best next step is to ask for a clear explanation about what it means for your or your child’s health, treatment options, and monitoring plans.

Sources

Public source information used for this glossary entry includes: